SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant community attention as investors anticipate the final 80th survival event in the Phase 3 REGAL trial, with bullish sentiment driven by strong institutional accumulation and the potential for a transformative oncology platform. While some market participants express caution regarding the timeline and hedging through put positions, the primary community focus remains on the extended survival data suggesting high efficacy of the GPS immunotherapy.

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending as investors react to a positive earnings report and subsequent analyst price target upgrades, fueling discussions around the company's advertising recovery and potential for long-term growth. While some investors see a turnaround driven by subscription revenue and AR technology, the community remains divided, with vocal critics expressing frustration over insider selling and ongoing concerns regarding platform litigation and leadership.

Infleqtion, Inc. engages in delivering neutral atom solutions for quantum computing, networking, sensing, and security. Its products are categorized into computing, sensing, and cores. The company was founded on February 7, 2007, and is headquartered in Louisville, CO.

Infleqtion Inc. - Ordinary Shares - Class A

Infleqtion Inc.

Infleqtion is seeing strong momentum as investors react to a record revenue performance and optimism surrounding its pivotal role in U.S. government quantum initiatives. The community is heavily focused on the company's competitive advantages in neutral-atom technology and anticipating significant upcoming catalysts from Department of Defense quantum sensing project selections.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is currently experiencing intense volatility and upward momentum as investors capitalize on a high-conviction short squeeze targeting high-profile bears, including Michael Burry. The community remains deeply polarized, with bulls pointing to strong capacity expansion and revenue growth, while bears emphasize valuation concerns, significant cash burn, and looming regulatory hurdles regarding site permits.

Investment Managers Series Trust II - Tradr 2X Short SNDK Daily ETF

Tradr 2X Short SNDK Daily ETF

The community is actively discussing the recent abandonment of a major factory expansion project and ongoing firmware-related lawsuits, fueling a bearish sentiment centered on the stock's long-term viability. Traders are aggressively debating these catalysts, with many using the 2X short ETF to capitalize on the high volatility and concerns regarding the company's competitive position against emerging memory manufacturers.

Dogecoin is an open-source digital currency based on the "Doge" meme that functions as a peer-to-peer medium for fast payments and digital tipping. Unlike projects backed by corporate entities, its value is driven by a global community, and the project is managed by a decentralized group of volunteers and the non-profit Dogecoin Foundation rather than a formal company.  Originally created in 2013 by software engineers Billy Markus and Jackson Palmer as a market parody, the project held no public sale or venture capital rounds. The network operates as a fork of LuckyCoin, which itself was a fork of Litecoin, using a proof of work consensus mechanism. It employs the Scrypt algorithm to ensure the mining process remains fast and efficient, with new blocks processed every 60 seconds. A unique technical feature is its use of merged mining, allowing miners to secure Dogecoin simultaneously with other Scrypt-based networks like Litecoin.  To keep transaction fees low and the network running indefinitely, Dogecoin features an uncapped supply where new coins are added forever. In a major regulatory milestone in March 2026, a joint SEC and CFTC framework officially classified Dogecoin as a digital commodity, placing it in the same asset category as gold or oil.

Dogecoin

Dogecoin is facing heightened scrutiny and bearish sentiment as traders debate its lack of fundamental utility and potential for further downside, despite some community interest in historical accumulation levels. Investors are increasingly divided, with many citing concerns over inflationary supply and broader capital rotation away from meme assets into other tech or market opportunities.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital Inc. is trending as investors monitor ongoing discussions regarding a potential data center tenant and anticipation for an upcoming conference call that may provide clarity on the company's operational progress. The community remains divided, with some highlighting the company's behind-the-meter energy strategy and institutional interest, while others express skepticism over recent earnings results and the limited number of full-time employees.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is seeing significant retail and institutional interest as traders look past recent security concerns and off-balance-sheet financing rumors to focus on its long-term AI networking and semiconductor demand. The community is actively debating whether the recent pullbacks represent an opportunistic buying window or a sign of deeper structural risks ahead of upcoming earnings.

Netlist, Inc. engages in the design, manufacture and sale of memory subsystems for the computing and communications markets. Its products include enterprise SSD, embedded flash, memory module, lightning DDR5 DIMM, SK hynix, AI server. The company was founded by Jayesh Bhakta, Chun Ki Hong and Christopher Lopes in June 2000 and is headquartered in Irvine, CA.

Netlist Inc

Netlist is trending as investors react to a major settlement with Samsung and growing expectations of additional lucrative licensing deals and patent victories against other memory giants. The community is actively discussing the stock's explosive momentum, the potential for a massive short squeeze due to high short interest, and the company's critical role in the expanding AI memory infrastructure.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The Financial Select Sector SPDR Fund is garnering significant attention as traders debate whether its recent resilience amid broader sector rotation indicates a durable trend or a temporary relief rally. Community members are actively analyzing the sector's performance through the lens of interest rate expectations, bank earnings, and shifting capital flows, leading to a polarized environment regarding its near-term price direction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Don't Overlook Bio-Rad (BIO) International Revenue Trends While Assessing the Stock

Explore Bio-Rad's (BIO) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad Reports Second-Quarter 2026 Financial Results

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2026. Norman Schwartz, Bio-Rads Chairman and Chief Executive Officer, stated: Second-quarter reported...

Bio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following the close of the market. Management will discuss these results in a...

Why Elliott Sees Hidden Billions Inside Bio-Rad Laboratories

Elliott Management builds a stake in Bio-Rad (NYSE: BIO) to push for better performance, but family voting control could pose a hurdle.read more...

Bio-Rad to Participate in Upcoming Investor Conferences

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following...

Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 12.8% - Time to Sell?

Bio-Rad Laboratories (NYSE:BIO.B) Trading Down 12.8% - Here's Why...

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down   - Should You Sell?

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down - Here's What Happened...

Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Average Rating of "Hold" from Analysts

Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO - Get Free Report) have earned an average rating of "Hold" from the five brokerages that are presently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, three have given a hold recommendat...

Unlocking Bio-Rad (BIO) International Revenues: Trends, Surprises, and Prospects

Explore how Bio-Rad's (BIO) revenue from international markets is changing and the resulting impact on Wall Street's predictions and the stock's prospects.

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. The Life Science segment includes development, manufacturing, and marketing of instruments, systems, reagents, and consumables used to separate, purify, characterize, and quantify biological materials. The Clinical Diagnostics segment focuses on designing, manufacturing, marketing, and support of diagnostic test systems, informatics solutions, test kits, and specialized quality controls for clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Bio-Rad Laboratories Inc. - Ordinary Shares - Class A

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

BIOBio-Rad Laboratories Inc. - Ordinary Shares - Class A

Fundamentals

Connect Stocktwits to ChatGPT

Latest BIO News